Chemokine Receptor 5 Δ32 Allele in Patients with Severe Pandemic (H1N1) 2009
Yoav Keynan1 , Jennifer Juno1, Adrienne Meyers, T. Blake Ball, Anand Kumar, Ethan Rubinstein, and Keith R. Fowke
Author affiliations: Author affiliations: University of Manitoba, Winnipeg, Manitoba, Canada (Y. Keynan, J. Juno, A. Meyers, T.B. Ball, A. Kumar, E. Rubinstein, K.R. Fowke); Public Health Agency of Canada, Winnipeg (A. Meyers, T.B. Ball)
Figure. Amplification of the chemokine receptor 5 (CCR5) Δ32 locus in white patients. Lane 1, heterozygous positive control; lanes 2–5 and 7–11, patient samples; lane 6, 100-bp ladder; lane 12, negative control. CCR5Δ32 heterozygosity is observed in samples 2, 3, 4, 5, and 11.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.